<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT942-14434</title>
	</head>
	<body>
		<main>
			<p>940420 FT  20 APR 94 / International Company News: Roche income advances 29% Roche, the Swiss pharma-ceuticals group, has again fulfilled its investors' high expectations by reporting a 29 per cent rise in 1993 consolidated net income to SFr2.48bn (Dollars 1.7bn). The directors have proposed a 30 per cent rise in the dividends to SFr48 per share and participation certificate. The group had earlier reported an 11 per cent rise in 1993 sales to SFr14.3bn, with all divisions contributing to the increase. Roche said its operating income had considerably increased, due to greater use of production capacity and cost management. Exact figures will be published with the annual report on May 10, but the group indicated that its operating margins had improved.</p>
		</main>
</body></html>
            